Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1
Condition: Hepatitis C, ChronicIntervention: Drug: Telaprevir and SofosbuvirSponsors: University of Florida; Vertex Pharmaceuticals IncorporatedCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials